Compile Data Set for Download or QSAR
maximum 50k data
Found 14 Enz. Inhib. hit(s) with all data for entry = 898
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297485(US10117944, Compound SDC-TRAP-0249)
Affinity DataIC50:  36nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297487(US10117944, Compound SDC-TRAP-0247)
Affinity DataIC50:  36nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297478(US10117944, Compound SDC-TRAP-0248)
Affinity DataIC50:  37nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297479(US10117944, Compound SDC-TRAP-0244)
Affinity DataIC50:  100nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297482(US10117944, Compound SDC-TRAP-0246)
Affinity DataIC50:  110nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297490(US10117944, Compound SDC-TRAP-0245)
Affinity DataIC50:  117nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297491(US10117944, Compound SDC-TRAP-0242)
Affinity DataIC50:  407nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297481(US10117944, Compound SDC-TRAP-0236)
Affinity DataIC50:  710nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297486(US10117944, Compound SDC-TRAP-0250)
Affinity DataIC50:  2.12E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297489(US10117944, Compound SDC-TRAP-0240)
Affinity DataIC50: >5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297488(US10117944, Compound SDC-TRAP-0251)
Affinity DataIC50: >5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297483(US10117944, Compound SDC-TRAP-0238)
Affinity DataIC50: >5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297480(US10117944, Compound SDC-TRAP-0237)
Affinity DataIC50: >5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals

US Patent
LigandPNGBDBM297484(US10117944, Compound SDC-TRAP-0239)
Affinity DataIC50: >5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent